Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

242.03
-1.3433-0.55%
Number of Gainers:4
Number of Losers:12
Number of Flat:- -
PE:- -
High:243.32
Open:243.32
Low:239.30
Close:243.37
Volume:11.23M
Turnover:34.21M
Market Cap:58.05B
Float Cap:51.09B

Loading ...

Aurora Optoelectronics Shareholder Transfers Stakes Through Court-Approved Process

MT Newswires Live
·
Sep 02

Five-Year Milestone Report Unveiled for Guangzhou Tianhe CBD National Digital Service Export Base

Deep News
·
Sep 02

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?

Simply Wall St.
·
Sep 02

Greenlane Names Bruce Linton Audit Committee Chair After Board Resignations

Reuters
·
Sep 02

DLP Resources’ Aurora PEA Confirms Large-Scale, High-Grade Copper-Moly Project in Peru

TIPRANKS
·
Sep 02

Aurora UK Alpha PLC Updates Share Buyback and Voting Rights

TIPRANKS
·
Sep 02

Introducing Trailpeak: Teva’s First High Performance Daily Trail Running Shoe Co-Created with the Brand’s Bureau of Adventure Athletes

THOMSON REUTERS
·
Sep 01

Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves

GlobeNewswire
·
Sep 01

Amphastar CFO Peters, EVP Marrs Present at Wells Fargo Healthcare Conference

Reuters
·
Sep 01

White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies

MT Newswires Live
·
Sep 01

Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...

Dow Jones
·
Sep 01

1414 Degrees Takes Full Control of Aurora Energy Precinct to Drive AI Data Centre and Renewable Hub

TIPRANKS
·
Sep 01

Stocks to Watch: Sono Group, Teva Pharmaceuticals, Pyxis Tankers, Metallus

Dow Jones
·
Sep 01

Teva to lower cost of select medicines for American patients covered by Medicaid

TIPRANKS
·
Sep 01

SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial

GlobeNewswire
·
Sep 01

Asian Equities Traded in the US as American Depositary Receipts Start Week Lower in Monday Trading

MT Newswires Live
·
Aug 31

AIM ImmunoTech Wins U.S. Patent Covering Ampligen-Keytruda Combo Cancer Therapy Through 2039

Reuters
·
Aug 31

AIM ImmunoTech Secures Broad U.S. Patent for Rintatolimod (Ampligen®) Used in Combination with Pembrolizumab (Keytruda®), Expanding Oncology Ip Protection for Ampligen Through 2039

THOMSON REUTERS
·
Aug 31

Dr. Reddy's Laboratories Falls Monday, Underperforms Market

Dow Jones
·
Aug 31

Cumberland Pharmaceuticals Updates Ifetroban DMD Trial Timeline

TIPRANKS
·
Aug 29